NasdaqGM - Delayed Quote • USD
Mirum Pharmaceuticals, Inc. (MIRM)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 6:35 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 14,576 | 10 |
| Sales | 35,894 | 16 |
| Net Shares Purchased (Sold) | -21,318 | 26 |
| Total Insider Shares Held | 1.05M | -- |
| % Net Shares Purchased (Sold) | -2.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BJERKHOLT ERIC H Chief Financial Officer | Purchase at price 24.80 per share. | Direct | 49,600 | Mar 27, 2024 |
| RADOVICH PETER President | Sale at price 25.80 per share. | Direct | 111,017 | Mar 25, 2024 |
| BJERKHOLT ERIC H Chief Financial Officer | Purchase at price 25.80 per share. | Direct | 51,600 | Mar 18, 2024 |
| PEETZ CHRISTOPHER Chief Executive Officer | Sale at price 26.19 per share. | Direct | 157,491 | Feb 2, 2024 |
| RADOVICH PETER President | Sale at price 26.19 per share. | Direct | 46,883 | Feb 2, 2024 |
| LONGPRE LARA Officer | Sale at price 26.19 per share. | Direct | 22,184 | Feb 2, 2024 |
| VIG PAMELA Officer | Sale at price 26.19 per share. | Direct | 31,797 | Feb 2, 2024 |
| HOWE JOLANDA Officer | Sale at price 26.19 per share. | Direct | 19,251 | Feb 2, 2024 |
| HOWE JOLANDA Officer | -- | Direct | -- | Jan 31, 2024 |
| PEETZ CHRISTOPHER Chief Executive Officer | Sale at price 28.03 per share. | Direct | 146,033 | Jan 8, 2024 |
| RADOVICH PETER Chief Operating Officer | Sale at price 28.03 per share. | Direct | 39,473 | Jan 8, 2024 |
| LONGPRE LARA Officer | Sale at price 28.04 per share. | Direct | 28,568 | Jan 8, 2024 |
| VIG PAMELA Officer | Sale at price 28.03 per share. | Direct | 39,472 | Jan 8, 2024 |
| HOWE JOLANDA Officer | Sale at price 28.04 per share. | Direct | 14,803 | Jan 8, 2024 |
| HOWE JOLANDA Officer | -- | Direct | -- | Jan 5, 2024 |
| HOWE JOLANDA Officer | Sale at price 32.40 per share. | Direct | 81,000 | Dec 5, 2023 |
| HOWE JOLANDA Officer | Conversion of Exercise of derivative security at price 2.94 per share. | Direct | 7,350 | Dec 5, 2023 |
| RADOVICH PETER Chief Operating Officer | Stock Award(Grant) at price 28.61 per share. | Direct | 6,237 | Nov 10, 2023 |
| LONGPRE LARA Officer | Stock Award(Grant) at price 28.61 per share. | Direct | 12,417 | Nov 10, 2023 |
| VIG PAMELA Officer | Stock Award(Grant) at price 28.61 per share. | Direct | 15,077 | Nov 10, 2023 |
| HERON PATRICK J Director | Purchase at price 28.30 per share. | Indirect | 82,353 | Nov 9, 2023 |
| GREY MICHAEL G. Director | Sale at price 32.00 per share. | Direct | 467,456 | Sep 14, 2023 |
| GREY MICHAEL G. Director | Conversion of Exercise of derivative security at price 2.94 per share. | Direct | 42,889 | Sep 14, 2023 |
| HERON PATRICK J Director | Purchase at price 31.02 per share. | Indirect | 81,425 | Sep 13, 2023 |
| HERON PATRICK J Director | Purchase at price 30.30 - 30.60 per share. | Indirect | 256,791 | Sep 12, 2023 |
| BJERKHOLT ERIC H Chief Financial Officer | Purchase at price 29.65 per share. | Direct | 296,492 | Sep 11, 2023 |
| HERON PATRICK J Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 26.25 per share. | Indirect | 3,884,764 | Aug 31, 2023 |
| HOWE JOLANDA Officer | Sale at price 26.23 per share. | Direct | 90,743 | Aug 25, 2023 |
| PEETZ CHRISTOPHER Chief Executive Officer | Sale at price 25.65 per share. | Direct | 141,005 | Jul 3, 2023 |
| RADOVICH PETER Chief Operating Officer | Sale at price 25.65 per share. | Direct | 36,546 | Jul 3, 2023 |
| LONGPRE LARA Officer | Sale at price 25.65 per share. | Direct | 25,749 | Jul 3, 2023 |
| VIG PAMELA Officer | Sale at price 25.65 per share. | Direct | 36,546 | Jul 3, 2023 |
| HOWE JOLANDA Officer | Sale at price 25.65 per share. | Direct | 23,467 | Jul 3, 2023 |
| HOWE JOLANDA Officer | -- | Direct | -- | Jun 30, 2023 |
| GREY MICHAEL G. Director | Sale at price 29.00 per share. | Direct | 423,632 | Jun 8, 2023 |
| GREY MICHAEL G. Director | Conversion of Exercise of derivative security at price 2.94 per share. | Direct | 42,889 | Jun 8, 2023 |
| PEETZ CHRISTOPHER Chief Executive Officer | Stock Award(Grant) at price 26.20 per share. | Direct | 32,907 | May 10, 2023 |
| RADOVICH PETER Chief Operating Officer | Stock Award(Grant) at price 26.20 per share. | Direct | 25,362 | May 10, 2023 |
| LONGPRE LARA Officer | Stock Award(Grant) at price 26.20 per share. | Direct | 17,921 | May 10, 2023 |
| VIG PAMELA Officer | Stock Award(Grant) at price 26.20 per share. | Direct | 17,921 | May 10, 2023 |
| GREY MICHAEL G. Director | Sale at price 28.00 per share. | Direct | 409,024 | May 3, 2023 |
| GREY MICHAEL G. Director | Conversion of Exercise of derivative security at price 2.94 per share. | Direct | 42,889 | May 3, 2023 |
| PEETZ CHRISTOPHER Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2023 |
| RADOVICH PETER Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2023 |
| LONGPRE LARA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2023 |
| VIG PAMELA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2023 |
| PEETZ CHRISTOPHER Chief Executive Officer | Sale at price 20.62 per share. | Direct | 106,390 | Jan 9, 2023 |
| RADOVICH PETER President | Sale at price 20.62 per share. | Direct | 28,438 | Jan 9, 2023 |
| LONGPRE LARA Officer | Sale at price 20.62 per share. | Direct | 20,684 | Jan 9, 2023 |
| VIG PAMELA Officer | Sale at price 20.62 per share. | Direct | 28,438 | Jan 9, 2023 |
Related Tickers
PHAT Phathom Pharmaceuticals, Inc.
9.10
-0.22%
IDYA IDEAYA Biosciences, Inc.
38.62
-3.09%
MRUS Merus N.V.
44.93
+7.05%
CALT Calliditas Therapeutics AB (publ)
19.45
+0.73%
IMCR Immunocore Holdings plc
58.00
-0.80%
ETNB 89bio, Inc.
8.25
-3.85%
MLTX MoonLake Immunotherapeutics
42.25
-0.42%
NAMS NewAmsterdam Pharma Company N.V.
21.44
-1.65%
ANAB AnaptysBio, Inc.
18.87
-2.08%
TVTX Travere Therapeutics, Inc.
5.39
-1.10%